Sano M, Fukuda K, Sato T, Kawaguchi H, Suematsu M, Matsuda S, Koyasu S, Matsui H, Yamauchi-Takihara K, Harada M, Saito Y, Ogawa S
Cardiopulmonary Division, Department of Internal Medicine, KeioUniversity School of Medicine, Shinjuku, Tokyo, Japan.
Circ Res. 2001 Oct 12;89(8):661-9. doi: 10.1161/hh2001.098873.
We recently reported that angiotensin II (Ang II) induced IL-6 mRNA expression in cardiac fibroblasts, which played an important role in Ang II-induced cardiac hypertrophy in paracrine fashion. The present study investigated the regulatory mechanism of Ang II-induced IL-6 gene expression, focusing especially on reactive oxygen species (ROS)-mediated signaling in cardiac fibroblasts. Ang II increased intracellular ROS in cardiac fibroblasts, and the increase was completely inhibited by the AT-1 blocker candesartan and the NADH/NADPH oxidase inhibitor diphenyleneiodonium (DPI). We first confirmed that antioxidant N-acetylcysteine, superoxide scavenger Tiron, and DPI suppressed Ang II-induced IL-6 expression. Because we observed that exogenous H(2)O(2) also increased IL-6 mRNA, the signaling pathways downstream of Ang II and exogenous H(2)O(2) were compared. Ang II, as well as exogenous H(2)O(2), activated ERK, p38 MAPK, and JNK, which were significantly inhibited by N-acetylcysteine and DPI. In contrast with exogenous H(2)O(2), however, Ang II did not influence phosphorylation and degradation of IkappaB-alpha/beta or nuclear translocation of p65, nor did it increase NF-kappaB promoter activity. PD98059 and SB203580 inhibited Ang II-induced IL-6 expression. Truncation and mutational analysis of the IL-6 gene promoter showed that CRE was an important cis-element in Ang II-induced IL-6 gene expression. NF-kappaB-binding site was important for the basal expression of IL-6, but was not activated by Ang II. Ang II phosphorylated CREB through the ERK and p38 MAPK pathway in a ROS-sensitive manner. Collectively, these data indicated that Ang II stimulated ROS production via the AT1 receptor and NADH/NADPH oxidase, and that these ROS mediated activation of MAPKs, which culminated in IL-6 gene expression through a CRE-dependent, but not NF-kappaB-dependent, pathway in cardiac fibroblasts.
我们最近报道,血管紧张素II(Ang II)可诱导心脏成纤维细胞中白细胞介素-6(IL-6)mRNA的表达,其以旁分泌方式在Ang II诱导的心脏肥大中发挥重要作用。本研究调查了Ang II诱导IL-6基因表达的调控机制,特别关注心脏成纤维细胞中活性氧(ROS)介导的信号传导。Ang II增加了心脏成纤维细胞内的ROS,而这种增加被AT-1阻滞剂坎地沙坦和NADH/NADPH氧化酶抑制剂二苯碘鎓(DPI)完全抑制。我们首先证实抗氧化剂N-乙酰半胱氨酸、超氧化物清除剂钛铁试剂和DPI可抑制Ang II诱导的IL-6表达。因为我们观察到外源性过氧化氢(H₂O₂)也会增加IL-6 mRNA,所以比较了Ang II和外源性H₂O₂下游的信号通路。Ang II以及外源性H₂O₂均可激活细胞外信号调节激酶(ERK)、p38丝裂原活化蛋白激酶(MAPK)和c-Jun氨基末端激酶(JNK),而N-乙酰半胱氨酸和DPI可显著抑制它们的活性。然而,与外源性H₂O₂不同,Ang II并不影响IκB-α/β的磷酸化和降解或p65的核转位,也不增加核因子κB(NF-κB)启动子活性。PD98059和SB203580可抑制Ang II诱导的IL-6表达。对IL-6基因启动子的截短和突变分析表明,环磷腺苷效应元件(CRE)是Ang II诱导IL-6基因表达中的一个重要顺式元件。NF-κB结合位点对IL-6的基础表达很重要,但未被Ang II激活。Ang II通过ERK和p38 MAPK途径以ROS敏感的方式使CREB磷酸化。总的来说,这些数据表明Ang II通过AT1受体和NADH/NADPH氧化酶刺激ROS生成,并且这些ROS介导了MAPKs的激活,最终通过心脏成纤维细胞中依赖CRE但不依赖NF-κB的途径导致IL-6基因表达。